Literature DB >> 2768645

Community-acquired pneumonia of diverse aetiology: prognostic features in patients admitted to an intensive care unit and a "severity of illness" core.

C Feldman1, J M Kallenbach, H Levy, S G Reinach, M D Hurwitz, J R Thorburn, H J Koornhof.   

Abstract

In a retrospective study of 73 patients with community-acquired lobar pneumonia of diverse aetiology admitted to an intensive care unit, an attempt was made to identify those factors among the demographic and clinical features and results of initial laboratory investigations that were predictive of the ultimate outcome. A lower mean white cell count (p = 0.03), platelet count (p = 0.02), total serum protein (p = 0.005) and albumin (p = 0.02) and a higher mean serum creatinine (p = 0.03) and phosphate level (p = 0.02) appeared to be predictive of a poor prognosis. The most significant variable predictive of mortality, was the presence of bacteraemia (p = 0.0005). Severity of illness scoring systems by omitting microbiological data appear to underestimate predicted patient mortality. The mortality rate of critically ill patients with community-acquired lobar pneumonia remains high, despite advances in antimicrobial chemotherapy and intensive care unit facilities, particularly in the presence of certain negative prognostic factors of which the presence of bacteraemia is the most important.

Entities:  

Mesh:

Year:  1989        PMID: 2768645     DOI: 10.1007/BF00263865

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  29 in total

1.  PNEUMOCOCCAL BACTEREMIA WITH ESPECIAL REFERENCE TO BACTEREMIC PNEUMOCOCCAL PNEUMONIA.

Authors:  R AUSTRIAN; J GOLD
Journal:  Ann Intern Med       Date:  1964-05       Impact factor: 25.391

2.  Pneumococcal pneumonia treated with antibiotics; the prognostic significance of certain clinical findings.

Authors:  T E VAN METRE
Journal:  N Engl J Med       Date:  1954-12-23       Impact factor: 91.245

3.  The effect of antibiotics (penicillin, aureomycin, and terramycin) on the fatality rate and incidence of complications in pneumococcic pneumonia; a comparison with other methods of therapy.

Authors:  H F DOWLING; M H LEPPER
Journal:  Am J Med Sci       Date:  1951-10       Impact factor: 2.378

4.  Regulation of albumin synthesis and catabolism by alteration of dietary protein.

Authors:  R Kirsch; L Frith; E Black; R Hoffenberg
Journal:  Nature       Date:  1968-02-10       Impact factor: 49.962

5.  Nutrition, immunity, and infection: present knowledge and future directions.

Authors:  R K Chandra
Journal:  Lancet       Date:  1983-03-26       Impact factor: 79.321

6.  Cellular immunity in semistarved states in hospitalized adults.

Authors:  B R Bistrian; G L Blackburn; N S Scrimshaw; J P Flatt
Journal:  Am J Clin Nutr       Date:  1975-10       Impact factor: 7.045

7.  Failure of intensive care unit support to influence mortality from pneumococcal bacteremia.

Authors:  E W Hook; C A Horton; D R Schaberg
Journal:  JAMA       Date:  1983-02-25       Impact factor: 56.272

Review 8.  Invasive pneumococcal infections: incidence, predisposing factors, and prognosis.

Authors:  L A Burman; R Norrby; B Trollfors
Journal:  Rev Infect Dis       Date:  1985 Mar-Apr

9.  Severe community-acquired pneumonia: factors influencing need of intensive care treatment and prognosis.

Authors:  A Ortqvist; G Sterner; J A Nilsson
Journal:  Scand J Infect Dis       Date:  1985

10.  The hospital management of community-acquired pneumonia. Recommendations of the British Thoracic Society.

Authors:  B D Harrison; B M Farr; C K Connolly; J T Macfarlane; J B Selkon; C L Bartlett
Journal:  J R Coll Physicians Lond       Date:  1987-10
View more
  20 in total

1.  BTS Guidelines for the Management of Community Acquired Pneumonia in Adults.

Authors: 
Journal:  Thorax       Date:  2001-12       Impact factor: 9.139

Review 2.  Prognosis factors in severe community-acquired pneumonia: a step forward.

Authors:  A Torres; M el-Ebiary
Journal:  Intensive Care Med       Date:  1996-12       Impact factor: 17.440

3.  Impact of management guidelines on the outcome of severe community acquired pneumonia.

Authors:  N A Hirani; J T Macfarlane
Journal:  Thorax       Date:  1997-01       Impact factor: 9.139

4.  Pneumonia Risk Stratification Scores for Children in Low-Resource Settings: A Systematic Literature Review.

Authors:  Katrina V Deardorff; Eric D McCollum; Amy Sarah Ginsburg
Journal:  Pediatr Infect Dis J       Date:  2018-08       Impact factor: 2.129

5.  Successful extracorporeal membrane oxygenation (ECMO) support for fulminant community-acquired pneumococcal pneumonia.

Authors:  M Codispoti; K Sanger; P S Mankad
Journal:  Thorax       Date:  1995-12       Impact factor: 9.139

6.  Penicillin G/ofloxacin versus erythromycin/amoxicillin-clavulanate in the treatment of severe community-acquired pneumonia.

Authors:  J Gaillat; J P Bru; A Sedallian
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-08       Impact factor: 3.267

7.  Quality of published reports of the prognosis of community-acquired pneumonia.

Authors:  C A Carson; M J Fine; M A Smith; L A Weissfeld; J T Huber; W N Kapoor
Journal:  J Gen Intern Med       Date:  1994-01       Impact factor: 5.128

8.  Acute alcohol intoxication impairs the hematopoietic precursor cell response to pneumococcal pneumonia.

Authors:  Caroline E Raasch; Ping Zhang; Robert W Siggins; Lynn R LaMotte; Steve Nelson; Gregory J Bagby
Journal:  Alcohol Clin Exp Res       Date:  2010-12       Impact factor: 3.455

9.  Community acquired, nursing home acquired and hospital acquired pneumonia: A five-year review of the clinical, bacteriological and radiological characteristics.

Authors:  C Chow; L Lee-Pack; N Senathiragah; M Rawji; M Chan; C Chan
Journal:  Can J Infect Dis       Date:  1995-11

10.  The effect of human immunodeficiency virus infection on the distribution and outcome of pneumonia in intensive care units.

Authors:  K J Tucker; B Anton; H J Tucker
Journal:  West J Med       Date:  1992-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.